Ronald Andrews

Immucor, Inc. develops, manufactures and sells transfusion and transplantation diagnostics products. It engages in the development, manufacture, and sale of products used by hospital blood banks, clinical laboratories, and blood donor centers to detect and identify certain properties of human blood prior to patient transfusion. The company was founded on May 19,1982 and is headquartered in Norcross, GA.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Oxford Immunotec Global Ltd. operates as a diagnostics company, which develops and commercializes proprietary tests for immunology and infectious disease. Its products include T-SPOT.TB, T-SPOT.CMV, T-SPOT.PRT and T-CELL XTEND. The company was founded by Peter James Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Insight Genetics, Inc. engages in the diagnosis, monitoring, and treatment of cancer. It specialize in the discovery, development, and commercialization of companion diagnostics. The company was founded in 2007 and is headquartered in Nashville, TN.

CancerLinQ LLC is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the world. The non-profit company is based in Alexandria, VA. The platform aims to improve the quality of patient care and accelerate discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics, treatments, and long-term side effects. By using data from nearly 7 million patient records in near real-time, CancerLinQ can improve health outcomes for all patients with cancer and advance evidence-based research. The company was founded in 2014. The CEO is Sean Khozin.

Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA.

Orion Health Group Ltd. engages in the provision of healthcare information technology advancing population health, and medicine solutions for personalized care across the entire health community. It operates through the geographical segment: North America (NA), Asia Pacific (APAC), Europe Middle East Africa (EMEA), and Corporate and Development. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Grafton, New Zealand.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

The Bethesda Group Fund invests in companies located in US. The fund target companies operating in the fields of Precision Medicine, Digital Health and Molecular Diagnostics. It provides financing for both early and growth stage capital requirements.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.